An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK announced that its drug Jemperli (dostarlimab) has received the US FDA ...
In the same year that the SFO launched its investigation into GlaxoSmithKline, China fined the drugs giant $490 million (£297 ...
UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...
Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a price target of ...
With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable vaccine Priorix for sale in the US looks timely. Priorix was first launched in Europe ...
Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...
Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today. The company’s shares opened today at ...
A design team including Haworth Tompkins, Metropolitan Workshop, dRMM and Studio Egret West is drawing up a major ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...